Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Amyris Names Steven Mills CFO

RELATED NEWS
Trade AMRS now with 

Amyris, Inc. (AMRS: Quote) said Wednesday that it has appointed Steven Mills as Chief Financial Officer, effective May 2.

Mills will replace Jeryl Hilleman, whose intent to depart during the course of this year was first announced in August 2011.

"Steve's three decade career at ADM brings the set of skills we need as we enter a new growth stage for our Company," said John Melo, President & Chief Executive Officer of Amyris.

Mills joined ADM in 1979 and served in various senior treasury and accounting roles, including as Chief Financial Officer from 2008 to 2010. During his most recent assignment, Mills served as ADM's Senior Executive Vice President, Performance and Growth where he helped drive growth through business development and acquisitions until his retirement from ADM in February.

Click here to receive FREE breaking news email alerts for Amyris and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
After trending higher over the past several sessions, stocks showed a lack of direction throughout the trading day on Friday before closing roughly flat. A muted reaction to a highly anticipated speech by Federal Reserve Chair Janet Yellen contributed to the lackluster performance. Republican Scott Brown has significantly narrowed the gap in the race against incumbent New Hampshire Sen. Jeanne Shaheen, D-N.H., according to the results of a new WMUR Granite State Poll. On the heels of the violent clashes between local police and protestors in Ferguson, Missouri, Sen. Claire McCaskill, D-Mo., announced that she will hold a Senate hearing in September to examine the militarization of local police departments.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.